收藏切换
The effects of bivalirudin combined with alprostadil on myocardial blood perfusion,hematological parameters and prognosis in patients with acute ST-segment elevation myocardial infarction after PCI
收藏切换
Shenglan LI, Kecheng WANG, Xin ZHANG, Xiangrui TANG*
World Clinical Drug | 2025, 46(5) : 476 - 482
Less
收藏切换
World Clinical Drug | 2025, 46(5): 476-482
• Article •
The effects of bivalirudin combined with alprostadil on myocardial blood perfusion,hematological parameters and prognosis in patients with acute ST-segment elevation myocardial infarction after PCI
Full
Shenglan LI, Kecheng WANG, Xin ZHANG, Xiangrui TANG*
Affiliations
  • Department of Cardiovascular, Hanzhong 3201 Hospital, Hanzhong 723000, Shaanxi Province, China
Published: 2025-05-10 doi: 10.13683/j.wph.2025.05.009
Outline
收藏切换
Objective

To explore the effect of bivalirudin combined with alprostadil on myocardial blood perfusion, hematological parameters and prognosis in patients with acute ST-segment elevation myocardial infarction (STEMI) after percutaneous coronary intervention (PCI).

Methods

A total of 294 patients with acute STEMI admitted to our hospital from January 2021 to November 2024 were selected and divided into control group A (treated with bivalirudin), control group B (treated with heparin+alprostadil), and observation group (treated with bivalirudin+alprostadil) according to the random number table method, with 98 cases in each group. The thrombolysis in myocardial infarction test (TIMI) blood flow classification, corrected TIMI flow frame count (CTFC) after surgery, and the rate of no-reflow phenomenon were compared before and 10 minutes after the operation among the three groups. The levels of serum interleukin (IL)-6, tumor necrosis factor (TNF)-α, C-reactive protein (CRP), and hematological parameters in the three groups before and 3 days after the operation were compared. The occurrence of major adverse cardiac event (MACE) within 30 days after PCI in the three groups was statistically analyzed.

Results

After the operation, the incidence of TIMI grade 3 in the observation group was higher than that in the control group (P<0.05), and the incidences of CTFC and the rate of no-reflow phenomenon were lower than those in the control group (P<0.05). Three days after the operation, the levels of serum IL-6, TNF-α, CRP, the ratio of neutrophil/lymphocyte, neutrophils, mean platelet volume, and the ratio of mean platelet volume/lymphocyte in the three groups were lower than those before the operation, while lymphocytes were higher than those before the operation (P<0.05), and (P<0.05). At 30 days after the operation, the incidence of MACE in the observation group was lower than that in the control group (P<0.05).

Conclusion

Bivalirudin combined with alprostadil can reduce the inflammatory response in patients with acute STEMI undergoing PCI, improve myocardial blood perfusion, and reduce the occurrence of postoperative MACE.

bivalirudin  /  alprostadil  /  acute ST-segment elevation myocardial infarction  /  percutaneous coronary intervention
李胜蓝, 王科程, 张鑫, 汤祥瑞. 比伐卢定联合前列地尔对急性ST段抬高型心肌梗死患者PCI术后心肌血流灌注、血液学参数及预后影响. 世界临床药物, 2025 , 46 (5) : 476 -482 . DOI: 10.13683/j.wph.2025.05.009
Shenglan LI, Kecheng WANG, Xin ZHANG, Xiangrui TANG. The effects of bivalirudin combined with alprostadil on myocardial blood perfusion,hematological parameters and prognosis in patients with acute ST-segment elevation myocardial infarction after PCI[J]. World Clinical Drug, 2025 , 46 (5) : 476 -482 . DOI: 10.13683/j.wph.2025.05.009
Year 2025 volume 46 Issue 5
49
12
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2025.05.009
  • Receive Date:2025-03-12
  • Online Date:2026-11-09
  • Published:2025-05-10
Article Data
Affiliations
History
  • Received:2025-03-12
Affiliations
    Department of Cardiovascular, Hanzhong 3201 Hospital, Hanzhong 723000, Shaanxi Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.05.009
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT